Procedures | Screening | Visit 1 | Visit 2 | Visit 3 | Visit 4 | Follow up |
---|---|---|---|---|---|---|
(Day 0) Baseline | (Day 30) | (Day 60) | (Day 90) Final visit | (Atleast 15 days from last visit) | ||
Informed consent | X | |||||
Medical history | X | |||||
Physical examination | X | X | X | X | X | |
Demographicsa | X | X | X | X | ||
Vital signsb | X | X | X | X | X | |
Hematology | X | X | ||||
Serum chemistry | X | X | ||||
Stool test for consistency | X | X | ||||
Urine pregnancy testc | X | |||||
Randomization | X | |||||
IP dispensing and dosing | X | X | X | |||
VAS assessment | X | X | X | X | ||
Gastrointestinal discomfort questionnaire | X | X | X | X | ||
Bristol stool score | X | X | X | X | ||
Physician’s global assessment | X | X | X | |||
Irritable bowel syndrome (IBS) quality of life questionnaire | X | X | X | X | ||
Adverse events (AEs) | X | X | X | X | X | |
Concomitant medications | X | X | X | X | X |